financetom
Business
financetom
/
Business
/
Aritzia Reports Higher Fourth-quarter Profit and Revenue; Issues Fiscal 2026 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aritzia Reports Higher Fourth-quarter Profit and Revenue; Issues Fiscal 2026 Outlook
May 25, 2025 11:49 PM

04:33 PM EDT, 05/01/2025 (MT Newswires) -- Aritzia ( ATZAF ) on Thursday said its fiscal fourth-quarter adjusted profit rose on higher sales.

The clothing retailer said its adjusted profit, excluding most one-time items, rose to $98 million, or $0.83 per share, in the quarter ended March 2, from $38.2 million, or $0.34 per share, a year ago. FactSet expected an adjusted profit of $0.70 per share.

Revenue rose 31% to $895.1 million from $682 million in the year-ago quarter. FactSet projected revenue of $845.8 million.

For fiscal 2026, Aritzia ( ATZAF ) expects net revenue to be between $3.05 billion and $3.25 billion, reflecting growth of about 11% to 19% from fiscal 2025. Adjusted earnings before interest, taxes, depreciation, and amortization are projected to be about 14% to 15% of net revenue, compared to 14.8% in fiscal 2025.

Looking further ahead, the retailer now anticipates capital cash expenditures between fiscal 2024 and fiscal 2027 to total about $750 million, up from the previously estimated $500 million. This increase is largely due to accelerated store growth and currency-related impacts, it added.

Aritzia ( ATZAF ) said it "continues to assess the direct and indirect impacts to its business of such tariffs, retaliatory tariffs or other trade protectionist measures implemented as this situation continues to develop, and such impacts could be material."

The company's shares closed up $1.11 to $49.60 on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved